Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Harrow Health Inc

HROW
Current price
9.67 USD +0.35 USD (+3.76%)
Last closed 9.31 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 326 945 792 USD
Yield for 12 month -21.95 %
Week
Month
Year
HROW
21.11.2021 - 28.11.2021

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic medicines, including IOPIDINE and MOXEZA; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and MAQ-100, a preservative-free triamcinolone acetonide ophthalmic injection drug candidate. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee. Address: 102 Woodmont Boulevard, Nashville, TN, United States, 37205

Analytics

WallStreet Target Price

28.13 USD

P/E ratio

Dividend Yield

Current Year

+88 595 000 USD

Last Year

+72 476 000 USD

Current Quarter

+34 265 000 USD

Last Quarter

+33 470 000 USD

Current Year

+63 212 000 USD

Last Year

+54 262 000 USD

Current Quarter

+24 198 000 USD

Last Quarter

+23 470 000 USD

Key Figures HROW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 12 608 000 USD
Operating Margin TTM 5.09 %
PE Ratio
Return On Assets TTM 1.15 %
PEG Ratio
Return On Equity TTM -37.26 %
Wall Street Target Price 28.13 USD
Revenue TTM 114 167 000 USD
Book Value 2.16 USD
Revenue Per Share TTM 3.71 USD
Dividend Share
Quarterly Revenue Growth YOY 50.1 %
Dividend Yield
Gross Profit TTM 63 212 000 USD
Earnings Share -0.44 USD
Diluted Eps TTM -0.44 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -64 %
Profit Margin -12.45 %

Dividend Analytics HROW

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History HROW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:5
Payout Ratio
Last Split Date 08.02.2013
Dividend Date

Stock Valuation HROW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.8814
Price Sales TTM 2.8638
Enterprise Value EBITDA 18.4775
Price Book MRQ 4.3204

Financials HROW

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators HROW

For 52 weeks

7.6 USD 28.25 USD
50 Day MA 12.79 USD
Shares Short Prior Month 6 262 518
200 Day MA 17.95 USD
Short Ratio 6.86
Shares Short 6 105 761
Short Percent 20.86 %